HomeINDOFARM › Filing
🔔 Get instant alerts when INDOFARM files quarterly results on BSE Start free trial →

Please see enclosed investor presentation.

Filed: 11 Aug 2026, 18:36 IST Exchange: BSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1FY27 - Revenue from operations ₹110.24 Cr, +14.5% y-y; EBITDA ₹15.51 Cr, +4.0% y-y; PAT ₹5.66 Cr, +4.1% y-y - Tractor division outlook positive with improving demand and capacity utilization to enhance margins - New pick & carry crane project at Bhud site progressing; commercial production expected in current FY - Tower crane prototype developed and tested; commercial production to start in current FY - NBFC subsidiary Barota Finance has ₹135 Cr loan book with 5,000+ active customers - Exports to 30+ countries; strong dealer network with 225+ tractor and 25+ crane dealers - Industry growth drivers: 6-7% CAGR for tractors, 5-7% CAGR for construction equipment
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 INDOFARM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add INDOFARM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Indo Farm Equipment Limited

Important. The summary above is generated automatically from Indo Farm Equipment Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.